A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MACI SEC filings page.
This page shows Melar Acquisition Corp. I (MACI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
The reported figures describe an acquisition vehicle whose liabilities exceed assets while non-operating items drive reported profit.
In FY2025, operating income was a loss of$1.5M , yet net income reached$5.5M . That reversal means the headline profit did not come from operating activity, but from items recorded outside it.
The balance sheet carried
Short-term assets of
Financial Health Signals
Melar Acquisition Corp. I does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
For every $1 of reported earnings, Melar Acquisition Corp. I used $0.14 of operating cash (-$774K OCF vs $5.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Melar Acquisition Corp. I reported an operating loss of $1.5M against $540K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Melar Acquisition Corp. I reported $720K in net income in Q2 2026. This represents a decrease of 53.7% from the same quarter a year earlier. Against the prior quarter it is down 7.5%.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Melar Acquisition Corp. I held $2K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
MACI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $629K+169.5% | $739K+371.0% | N/A | $712K+446.1% | $233K+163.3% | $157K | N/A | $130K |
| Operating Income | -$629K-169.5% | -$739K-371.0% | N/A | -$712K-446.1% | -$233K-163.3% | -$157K | N/A | -$130K |
| Interest Expense | $167K+152716.5% | $153K | N/A | $384K | $109 | N/A | N/A | N/A |
| Net Income | $720K-53.7% | $778K-50.7% | N/A | $1.1M-53.3% | $1.6M+1364.0% | $1.6M | N/A | $2.4M |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
MACI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $47.0M-72.2% | $176.9M+5.9% | $175.3M+5.9% | $173.8M+6.1% | $168.9M+4.6% | $167.1M | $165.5M | $163.7M |
| Current Assets | $4.2M+324.5% | $4.0M+337.6% | $3.9M+274.5% | $4.0M+266.1% | $978K-19.1% | $916K | $1.0M | $1.1M |
| Cash & Equivalents | $2K-99.6% | $14K-98.0% | $32K-96.3% | $286K-69.4% | $556K-46.4% | $693K | $878K | $934K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $50.5M-71.1% | $184.7M+6.9% | $182.3M+6.6% | $180.4M+6.7% | $174.8M+4.7% | $172.8M | $171.0M | $169.1M |
| Current Liabilities | $5.9M+1927.9% | $5.1M+15528.2% | $4.3M+10311.5% | $4.1M+35710.9% | $292K+82.0% | $33K | $41K | $11K |
| Non-Current Liabilities | $44.6M-74.5% | $179.5M+3.9% | $178.0M+4.1% | $176.3M+4.3% | $174.5M+4.7% | $172.7M | $171.0M | $169.1M |
| Total Equity | -$3.5M+41.1% | -$7.7M-35.9% | -$7.0M-26.4% | -$6.6M-22.6% | -$5.9M-9.3% | -$5.7M | -$5.5M | -$5.4M |
| Retained Earnings | -$3.5M+41.1% | -$7.7M-35.9% | -$7.0M-26.4% | -$6.6M-22.6% | -$5.9M-9.3% | -$5.7M | -$5.5M | -$5.4M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
MACI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
MACI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$7.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.91), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Melar Acquisition Corp. I MACI | FY2025 | N/A | $5.5M | N/A | $106.0M | — |
| Hennessy Capital Investment Corp. VII HVII | FY2025 | N/A | $3.7M | N/A | $116.1M | — |
| SIM Acquisition Corp. I Unit SIMAU | FY2025 | N/A | $8.8M | N/A | $255.5M | — |
| Stellar V Capital Corp. Unit SVCCU | FY2025 | N/A | $5.3M | N/A | N/A | — |
| Archimedes Tech SPAC Partners II Co. Unit ATIIU | FY2025 | N/A | $8.0M | N/A | N/A | — |
Where Melar Acquisition Corp. I Ranks
Frequently Asked Questions
Is Melar Acquisition Corp. I profitable?
Yes, Melar Acquisition Corp. I (MACI) reported a net income of $5.5M in fiscal year 2025.
What is Melar Acquisition Corp. I's operating cash flow?
Melar Acquisition Corp. I (MACI) recorded an outflow of $774K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Melar Acquisition Corp. I's total assets?
Melar Acquisition Corp. I (MACI) had $175.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Melar Acquisition Corp. I's current ratio?
Melar Acquisition Corp. I (MACI) had a current ratio of 0.91 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Melar Acquisition Corp. I's return on assets (ROA)?
Melar Acquisition Corp. I (MACI) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Melar Acquisition Corp. I's P/E ratio?
Melar Acquisition Corp. I (MACI) trades at 19.1x earnings, its market capitalization divided by net income of $5.5M net income, FY2025. The market capitalization is $106.0M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Melar Acquisition Corp. I's price-to-sales ratio?
Melar Acquisition Corp. I (MACI) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $106.0M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is Melar Acquisition Corp. I's debt-to-equity ratio negative or not reported?
Melar Acquisition Corp. I (MACI) has negative shareholder equity of -$7.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are Melar Acquisition Corp. I's earnings high quality?
For every $1 of reported earnings, Melar Acquisition Corp. I (MACI) used $0.14 of operating cash (-$774K OCF vs $5.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Melar Acquisition Corp. I cover its interest payments?
Melar Acquisition Corp. I (MACI) reported an operating loss of $1.5M against $540K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.